Cargando…
Remarkable response to alectinib for metastatic papillary thyroid cancer with STRN-ALK fusion: A case report
Little is known about the efficacy of alectinib for papillary thyroid cancer with STRN-ALK fusion. A 64-year-old female presented with metastatic papillary thyroid cancer, widespread to lungs, mediastinal lymph nodes and brain 20 years after surgery. Disease progression still occurred after radioact...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682147/ https://www.ncbi.nlm.nih.gov/pubmed/36439495 http://dx.doi.org/10.3389/fonc.2022.1009076 |